Back

Value-based versus usual care for heart failure patients leads to reduction in cost, hospital admissions and improved survival

30 August 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Drug therapy for heart failure: what is new? Multidisciplinary Interventions ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Jerifaye Flores

Las Vegas (United States of America)

8 More presentations in this session

Presentation thumbnail
Effects of Sacubitril/Valsartan on all-cause hospitalizations in heart failure: participant-level pooled analysis of PARADIGM-HF and PARAGON-HF
Doctor H. Lu (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Tafamidis treatment for transthyretin amyloid cardiomyopathy: results from an open-label, early-access, long-term study extension in an all-comers population
Professor M. Crespo-Leiro (A Coruna, ES)
Abstract Slides Video
Presentation thumbnail
Efficacy of sotagliflozin by diabetes duration: a secondary analysis of SCORED
Doctor R. Aggarwal (Boston, US)
Abstract Slides Video
Presentation thumbnail
Effects of dapagliflozin in heart failure according to duration of type 2 diabetes: a patient-level meta-analysis of DAPA-HF and DELIVER
Doctor J. Butt (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Long-term follow-up of the TRED-HF trial
Miss L. Cheng (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Drug therapy for heart failure: what is new?

The Event

Event poster

ESC Congress 2024

30 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Influence of process-focused patient care on clinical outcomes among hospitalized heart failure patients in the cardiology ward
1 September 2024
thumbnail
Congress Session
Using big data to drive cardiovascular innovations
31 August 2025
thumbnail
Congress Presentation
Sex-specific clinical outcomes and healthcare resource utilization in the 5 years following hospitalization for heart failure
12 May 2024
thumbnail
Congress Presentation
Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: Real-life data from the Swedish Heart Failure Registry 2013-2020
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources